The monographs of the European Pharmacopoeia as amended by Supplements published by the Council of Europe are reproduced either in the British Pharmacopoeia, or in the associated edition of the British Pharmacopoeia Veterinary. In the pharmacopoeia, certain drugs and preparations are included regardless of the existence of actual or potential patent rights. Where substances are protected by letters patent , their inclusion in the pharmacopoeia neither conveys, nor implies, licence to manufacture. The first list of approved drugs, with information on how they should be prepared, was the London Pharmacopoeia, published in The first edition of what is now known as the British Pharmacopoeia was published in , and was one of the first attempts to harmonise pharmaceutical standards, through the merger of the London, Edinburgh and Dublin Pharmacopoeias. A commission was first appointed by the General Medical Council GMC , when the body was made statutorily responsible under the Medical Act for producing a British pharmacopoeia on a national basis.
|Published (Last):||24 May 2016|
|PDF File Size:||20.39 Mb|
|ePub File Size:||11.66 Mb|
|Price:||Free* [*Free Regsitration Required]|
Purchasers can download a free scanned copy of the original book without typos from the publisher. Not indexed. Not illustrated. It is recommended for local application in orchids and mumps. An ointment of methyl salicylate with hydrous wool fat i in 8 is prepared for use in rheumatism and neuralgia, menthol i in 16 being sometimes added.
Methyl salicylate is used internally in acute and chronic rheumatism enclosed in a gelatin capsule 5 or 10 minims in each. It may be emulsified with mucilage of acacia and given in mixture form, but its taste is pungent and objectionable.
It is used as a flavouring agent and as an antiseptic in mouth washes, tooth pastes, and powders. Methylrosaniline is a mixture of the hydrochlorides of penta-and hexa-methyl-para-rosanilines, formed by the oxidation of dimethyl aniline with cupric salts.
It occurs as a green mass with a metallic lustre, or as a greencrystalline powder. Soluble in water i in 75 and in alcohol i in 20 , the solution having a violet colour, and being decomposed by exposure to light.
The colour becomes green in presence of acids. Methyl violet has been employed for the internal and local treatment of malignant tumours; also for cardiac dropsy, and as a local application in diphtheria. As a lotion, a i per cent, solution may be used, a weaker solution i in being used as an injection. A dusting powder is prepared with i of methyl violet and 9 of boric acid; this is ap
Find out more about what we are doing in response to COVID-19
British Pharmaceutical Codex
British pharmaceutical codex.
Pharmaceutical Codex pdf